Emergency Management of Allergic Reaction with Acute Desaturation
Immediately administer intramuscular epinephrine 0.3-0.5 mg (1:1000 solution) into the anterolateral thigh, provide 100% supplemental oxygen, position the patient supine with legs elevated, establish IV access for aggressive fluid resuscitation, and prepare for advanced airway management if respiratory distress worsens. 1
Immediate First-Line Actions (Within Seconds to Minutes)
Epinephrine Administration - The Critical Priority
Epinephrine is the cornerstone and only first-line treatment for anaphylaxis causing desaturation 1, 2. Delayed epinephrine administration is directly implicated in anaphylaxis fatalities 2.
- Dose: 0.2-0.5 mg intramuscular (1:1000 solution, which is 1 mg/mL)
- Route: Intramuscular into the anterolateral thigh (NOT subcutaneous - IM produces rapid peak plasma concentrations) 1
- Repeat: Every 5-15 minutes as needed if symptoms persist 1, 2
- No absolute contraindications exist - the risk of death from untreated anaphylaxis outweighs any theoretical cardiac concerns 3
Airway and Breathing Management
Given acute desaturation, respiratory involvement is life-threatening:
- Administer 100% oxygen immediately via non-rebreather mask 3
- Assess for laryngeal edema (stridor, voice changes, difficulty swallowing) - this requires immediate referral to someone skilled in surgical airway management 1
- Prepare for intubation if inspiratory stridor or dyspnea at rest develops 4
- Nebulized albuterol (3 mL in adults, 1.5 mL in children) for bronchospasm, but this is adjunctive only and does NOT treat laryngeal edema 2, 3
Circulation Support
Anaphylaxis can cause transfer of up to 35% of intravascular volume into extravascular space within minutes 3:
- Position supine with legs elevated (unless respiratory distress worsens in this position) 2
- Establish large-bore IV access immediately
- Aggressive fluid resuscitation with normal saline - give 10-20 mL/kg bolus rapidly for hypotension 5, 3
- Any patient not responding promptly to IM epinephrine should be assumed to have intravascular volume depletion 3
Escalation for Severe/Refractory Cases
When IM Epinephrine is Insufficient
If the patient remains hypotensive or in severe respiratory distress after 2-3 IM doses:
- Consider IV epinephrine (0.05-0.1 mg of 1:10,000 solution as slow bolus, OR continuous infusion at 0.1 mg/mL) 1, 6
- IV epinephrine requires continuous hemodynamic monitoring and should only be given by those experienced with its use 1, 6
- Vasopressors (e.g., metaraminol) may be needed for refractory hypotension despite epinephrine and fluids 6, 3
Special Consideration: Beta-Blocker Use
If the patient takes beta-blockers and is refractory to epinephrine:
- Administer glucagon 1-5 mg IV over 5 minutes (pediatric: 20-30 μg/kg, max 1 mg) 3
- Glucagon has inotropic/chronotropic effects not mediated through beta-receptors 3
- May repeat or follow with infusion of 5-15 μg/min 3
- Warning: Rapid glucagon administration causes vomiting 3
Bradycardia Management
- Atropine IV for persistent bradycardia 3
Secondary Adjunctive Treatments (NOT Substitutes for Epinephrine)
These have limited evidence but are commonly used 1, 3:
H1 Antihistamines
- Diphenhydramine 25-50 mg IV or oral 2, 3
- Only relieves urticaria and itching - does NOT treat airway obstruction, bronchospasm, or shock 3
- Never substitute for or delay epinephrine 3
Corticosteroids
- Hydrocortisone 200 mg IV (adult dose) or methylprednisolone 1-2 mg/kg 6
- Onset of action is 4-6 hours - NOT helpful for acute phase 3
- May prevent biphasic reactions (which occur in up to 20% of cases within 1-72 hours) 3
H2 Antihistamines
Critical Pitfalls to Avoid
- Delaying epinephrine while trying antihistamines first - this is the most common fatal error 2
- Using subcutaneous instead of intramuscular route - IM absorption is faster 1
- Giving epinephrine in wrong concentration - IM uses 1:1000 (1 mg/mL); IV uses 1:10,000 (0.1 mg/mL) 1, 6
- Assuming normal pulse oximetry rules out anaphylaxis - clinical symptoms trump objective measures 5
- Discharging too early - observe 4-6 hours minimum; longer if severe symptoms 2
Post-Resuscitation Management
- Monitor continuously until complete symptom resolution
- Obtain mast cell tryptase levels: at presentation, 1-2 hours post-symptom onset, and at 24 hours for baseline 6
- Observe minimum 4-6 hours; admit if severe, refractory, or requiring multiple epinephrine doses 2
- Discharge with two epinephrine auto-injectors and emergency action plan 2
- Mandatory allergist referral for trigger identification and long-term management 1, 2
If Cardiac Arrest Occurs
- Standard BLS/ACLS takes priority 1
- High-dose IV epinephrine (1-3 mg of 1:10,000 solution IV over 3 minutes, then 3-5 mg, then 4-10 mg/min infusion) 7
- Prolonged resuscitation efforts are warranted - anaphylaxis patients are often young with healthy cardiovascular systems 7
- Massive volume resuscitation is essential 7